Carlos Gallardo is the Founder and CEO of CG Health Ventures, a company specializing in building and investing in digital health startups globally. With a strong entrepreneurial spirit, Carlos focuses on identifying challenges in the health sector that can be addressed through technological innovation. He is dedicated to nurturing talented entrepreneurs, envisioning the future of healthcare, and embracing new technologies.

Carlos holds an MBA from Stanford University Graduate School of Business and an MS in Industrial Engineering from Universitat Politècnica de Catalunya. His educational background equips him with a solid foundation of business and engineering knowledge.

Over the years, Carlos Gallardo has held various key positions in organizations, including Chairman of the Board at Almirall and roles like Founder and CEO, Vice President of the Board of Directors, Managing Director UK, Director Corporate Development, Licensing Manager, and Strategy & Strategic Planning Manager at Almirall. Additionally, he has worked as a Venture Partner, Digital Health at Ysios Capital and as a Business Analyst at Pfizer.

Carlos actively engages in advising, mentoring, investing, and establishing high-growth companies that focus on leveraging technology and personalized care to enhance patient health outcomes. His dedication to supporting innovation in healthcare reflects his passion for utilizing technology and talent to drive positive changes in the industry.